Journal of Clinical and Translational Hepatology

Journal of Clinical and Translational Hepatology

Friday, 09 / 25 / 2020

Articles

What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective

REVIEW ARTICLE

What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective

Nahum Méndez-Sánchez, Alejandro Valencia-Rodríguez, Xingshun Qi, Eric M. Yoshida, Manuel Romero-Gómez, Jacob George, Mohammed Eslam, Ludovico Abenavoli, Weifen Xie, Rolf Teschke, Andres F. Carrion and Andrew P. Keaveny

Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico
Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico
Department of Gastroenterology, General Hospital of Northern Theater Command (Formerly General Hospital of Shenyang Military Area), Shenyang, China
Division of Gastroenterology, University of British Columbia, Vancouver, BC, Canada
UCM Digestive Diseases and CIBERehd, Institute of Biomedicine of Seville (IBiS), SeLiver Group, Virgen del Rocío University Hospital, University of Seville, Seville, Spain
Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, NSW, Australia
Department of Health Sciences, University Magna Graecia of Catanzaro, Italy
Department of Gastroenterology, Changzheng Hospital of the Second Military Medical University, Shanghai, China
Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt/Main, Hanau, Germany
10 Division of Gastroenterology and Hepatology, University of Miami, Miller School of Medicine, Miami, FL, USA
Department of Transplantation, Mayo Clinic, Jacksonville, Florida, USA

*Correspondence to: Nahum Méndez-Sánchez, Liver Research Unit, Medica Sur Clinic and Foundation, National Autonomous University of Mexico, Puente de Piedra 150, Col. Toriello Guerra, ZP 14050, México City, México. Tel: +525-55424-4629E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it.

Journal of Clinical and Translational Hepatology 2020;8(2):109-112 DOI: 10.14218/JCTH.2020.00024
Received: April 4, 2020 Accepted: April 5, 2020 Published online: April 11, 2020

Abstract

As of today, March 30, 2020, when this Editorial is being written, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causal agent of the coronavirus disease (COVID-19) has been confirmed in more than 745,000 cases worldwide and has claimed the lives of more than 35,000 people.1 In addition to the morbidity and mortality associated with COVID-19, this betacoronavirus has placed several of the world’s major economies in strife, mainly in Western Europe and North America, paralyzing travel and regular social interactions, making COVID-19 undoubtedly one of the most important pandemics in human history.

While we are in the midst of battling this pandemic, we have already learned some lessons from a cruel teacher: a) the importance of a strong association that must exist between governments and the scientific community in implementing a broad range of measures to contain and, in the future, prevent this type of epidemic; b) the potential for this pandemic to indirectly, due to less available resources, increase liver-related outcomes morbidity and mortality, including liver transplantation; c) the necessity to develop new working practices in multidisciplinary teams that will provide appropriate levels of care for patients from intensive care units to the outpatient setting. COVID-19 may make virtual clinic visits through telemedicine the norm and not the exception in some parts of the world. However, there are many questions that have yet to be answered. One of the most important to resolve is the understanding of the devastating impact of SARS-CoV-2 in specific geographic regions, such as Spain and Italy.

 

Journal of Clinical and Translational Hepatology 2020 vol. 8, 109-112  [ Html ] [ PDF Full-text ]

© The Authors 2020. This article is published under the terms of the Creative Commons Attribution-Noncommercial License (CC BY-NC 4.0), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non-commercial and is otherwise in compliance with the license.

 logo

You are here: Home